Citadel Advisors’s Nature's Sunshine NATR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-100
Closed -$1.25K – 14159
2025
Q1
$1.25K Buy
+100
New +$1.41K ﹤0.01% 14154
2024
Q4
– Sell
-200
Closed -$2.72K – 15081
2024
Q3
$2.72K Sell
200
-1,000
-83% -$14.3K ﹤0.01% 13723
2024
Q2
$18.1K Buy
+1,200
New +$20.5K ﹤0.01% 12726
2024
Q1
– Sell
-10,700
Closed -$185K – 15175
2023
Q4
$185K Buy
10,700
+7,300
+215% +$126K ﹤0.01% 10062
2023
Q3
$56.3K Buy
+3,400
New +$51.6K ﹤0.01% 11612
2023
Q2
– Sell
-1,200
Closed -$12.3K – 14919
2023
Q1
$12.3K Buy
1,200
+900
+300% +$8.85K ﹤0.01% 13426
2022
Q4
$2.5K Buy
+300
New +$2.54K ﹤0.01% 14326

Other funds holding NATR

Citadel Advisors's NATR Position: Q2 2026 in Review

Citadel Advisors sold out of Nature's Sunshine (NATR) in Q2 2026, closing a stake of 43,665 shares — an estimated $1.05M sold.

Citadel Advisors first reported a position in NATR in Q3 2013 and held it in 21 quarters. The position peaked at $1.05M in Q1 2026. 153 funds tracked by Wall St. Rank hold NATR as of Q2 2026.

  • Citadel Advisors reported no remaining Nature's Sunshine position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 43,665 Nature's Sunshine shares in Q2 2026, an estimated $1.05M.
  • Citadel Advisors first reported a position in Nature's Sunshine in Q3 2013 and held it in 21 quarters.
  • Citadel Advisors's Nature's Sunshine position peaked at $1.05M in Q1 2026.
  • 153 funds tracked by Wall St. Rank held Nature's Sunshine as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.